A Prospective Study of Anemia Profile of Chronic Liver Diseases Patients

Title: A Prospective Study of Anemia Profile of Chronic Liver Diseases Patients

Authors: Naimish Patel, Neha Shah

DOI: https://dx.doi.org/10.18535/jmscr/v5i2.145

Abstract

The present prospective study was conducted to evaluate the prevalence of anemia, its type and therapeutic measures in chronic liver disease (CLD) patients. In cross sectional study of anemia profile including, Complete Blood Count (CBC), reticulocyte count, S. Iron, S. Ferritin, S. TIBC, G6PD, S.B12 and Coomb test was done in all selected CLD patients included in study. The therapy of anemia was also analyzed. In CLD cases 88% patients suffering from anemia. Most common type of anemia is normocytic normochromic. Macrocytic anemia is associated with history of alcoholism. Anemia can be treated with replacement of PCV and replacement of vitamin B12 and Folic acid therapy.

Keywords: Anemia, Chronic Liver Disease, Therapeutic.

References

1. Middle-East Journal of Scientific Research 14 (4): 461- 470, 2013 ISSN 1990-9233,© IDOSI Publications, 2013 DOI: 10.5829/idosi.mejsr.2013.14.4.7321.

2. Macdougall, I.C., CERA (Continuous Erythropoietin Receptor Activator), 2005. A new erythropoiesis- stimulating agent for the treatment of anemia. Curr. Hematol. Rep., 4: 436-40.

3. McHutchison, J.G., M.P. Mannsand and D.L. Longo, 2006. Definition and management of anemia in patients infected with hepatitis C virus. Liver Int.,26: 389-398.

4. Schmidt, Sca J. Hematol, 1983. 30: 465

5. Rubiee, Cry Med, 1977. 40: 338.

6. Garcia-Pagan, J.C., A. De Gottardiand J.Bosch,2008. Review article: the modern management of portal hypertension--primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Aliment Pharmacol Ther., 28: 178-186 [PubMed].

7. Kravetz, D., 2007. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations. J. Clin Gastroenterol., 41(Suppl 3): S318-S322 [PubMed].

8. Albillos, A., 2007. Preventing first variceal hemorrhage in cirrhosis. J. Clin Gastroenterol., 41(Suppl 3): S305-S311 [PubMed].

Call For Paper Volume 12 Issue 12 December 2024

The JMSCR is accepting manuscripts for its coming issues to be Publish Volume 12 Issue 12 December 2024 the JMSCR invites authors to submit manuscripts Reporting original medical research, original article, research article, case report, systematic reviews, or educational Innovations for publication for the coming issues that will be released in Volume 12 Issue 12 December 2024. Types of manuscripts suitable for JMSCR include: Medical research, Clinical research Educational Innovation, Brief Report, Reviews on Teaching In keeping with high quality scholarship, Read More.....

https://jmscr.igmpublication.org/ems/index.php/jmscr/about/submissions

If any difficulty you can also submit to: This email address is being protected from spambots. You need JavaScript enabled to view it.

JMSCR Menu

Impact Factor SJIF 2024: 7.892

https://sjifactor.com/passport.php?id=1725

Crossref - DOI

Crossref - DOI Prefix: 10.18535/jmscr

Editorial Policy

Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not ..

Frequency of Publication

JMSCR is published as monthly journal with 12 issues per year. Special editions are also planned subjected to the scope and need....

Submission of Articles

Authors are invited to submit their research articles, review papers, Case Report properly formatted as per the author guidelines.........

Search